Efficacy Study of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

Condition:   Oral Mucositis Interventions:   Drug: RRx-001 + eLOOP Device;   Radiation: Intensity-modulated radiation therapy;   Drug: Cisplatin for injection 100 mg/m2 Sponsor:   EpicentRx, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials